News | August 19, 2008

Radiosurgery Clinicians Present Latest Advances in Brain, Spine Treatments

August 20, 2008 – Integra LifeSciences Holdings Corp. said its Radionics XKnife clinicians presented their latest advances in the treatment of brain and spine tumors on Sunday, July 27 at the 50th annual meeting of the American Association of Physicists in Medicine in Houston.

Satish Jaywant, M.D., associate professor of radiation oncology at Robert Wood Johnson University Hospital in New Brunswick, NJ, presented his latest work using Radionics XKnife and ImageFusion software and cone beam CT to achieve stereotactic accuracy for extracranial targets.

Nilendu Gupta, M.D., associate professor and chief of clinical medical physics at James Cancer Center at the Ohio State Medical Center in Columbus, OH, presented his work in commissioning the Xknife system for stereotactic spine treatments.

Emilie Soisson, medical physicist and assistant researcher at the University of Wisconsin Hospital and Clinics, presented her work on the Radionics InterFix system for intracranial stereotactic positioning for use on the TomoTherapy Hi – Art system.

Unlike conventional surgery, XKnife radiosurgery is completely noninvasive and does not require a surgical incision. Cancerous or other diseased tissue can be treated with focused radiation beams from a linear accelerator (linac) that are precisely guided using computer tomography (CT), magnetic resonance imaging (MRI) and positron emission tomography (PET) images. Surrounding normal tissue is spared and patients are typically able to leave the hospital immediately after their treatment. To date, over 45,000 patients have undergone Radionics Xknife radiosurgery, said the company.

For more information: www.integra-LS.com

Related Content

World's largest radiation oncology meeting will offer full conference on interactive platform October 25-28, 2020
News | ASTRO | July 09, 2020
July 9, 2020 — Registration opens today for the American Society for Radiation Oncology's (...
Radiotherapy has been used to treat cancers for more than a century and continues to be utilized in cancer treatment plans today. Since the introduction of radiotherapy, clinicians have been working tirelessly to further refine treatments to better target cancer.
Feature | Radiation Therapy | July 06, 2020 | By Yves Archambault
Everything has room for improvement, right? Right. When it comes to cancer care, it is no different.
Proton therapy has evolved, and future predictions include smaller systems, more sophisticated proton dosimetry and devices that manipulate the proton beam
Feature | Proton Therapy | July 06, 2020 | By Minesh Mehta, M.D.
The field of proton...
News | Proton Therapy | June 16, 2020
June 17, 2020 — RaySearch Laboratories AB launched the latest release of its widely adopted treatment planning system
Vacancy rates for radiation therapists rose substantially since 2018, according to a survey performed this year by the American Society of Radiologic Technologists. Researchers noted, however, the survey data was collected before the COVID-19 pandemic began affecting the surveyed clinical settings.

Getty Images

News | Radiation Therapy | June 05, 2020
June 5, 2020 — Vacancy rates for radiation therapists rose substantially since 2018, according to a survey performed
MERCK and RefleXion Medical announced a collaboration to evaluate KETRUDA (immunotherapy) with biology-guided radiotherapy - BgRT -  a new radiation machine developed to treat all stages of cancer.

MERCK and RefleXion Medical announced a collaboration to evaluate KETRUDA (immunotherapy) with biology-guided radiotherapy - BgRT -  a new radiation machine developed to treat all stages of cancer.

 

News | Radiation Therapy | June 01, 2020
June 1, 2020 — RefleXion Medical, a therape